Literature DB >> 15737992

Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.

Junjie Hu1, Stevan R Hubbard.   

Abstract

The Cbl adapter proteins typically function to down-regulate activated protein tyrosine kinases and other signaling proteins by coupling them to the ubiquitination machinery for degradation by the proteasome. Cbl proteins bind to specific tyrosine-phosphorylated sequences in target proteins via the tyrosine kinase-binding (TKB) domain, which comprises a four-helix bundle, an EF-hand calcium-binding domain, and a non-conventional Src homology-2 domain. The previously derived consensus sequence for phosphotyrosine recognition by the Cbl TKB domain is NXpY(S/T)XXP (X denotes lesser residue preference), wherein specificity is conferred primarily by residues C-terminal to the phosphotyrosine. Cbl is recruited to and phosphorylated by the insulin receptor in adipose cells through the adapter protein APS. APS is phosphorylated by the insulin receptor on a C-terminal tyrosine residue, which then serves as a binding site for the Cbl TKB domain. Using x-ray crystallography, site-directed mutagenesis, and calorimetric studies, we have characterized the interaction between the Cbl TKB domain and the Cbl recruitment site in APS, which contains a sequence motif, RA(V/I)XNQpY(S/T), that is conserved in the related adapter proteins SH2-B and Lnk. These studies reveal a novel mode of phosphopeptide interaction with the Cbl TKB domain, in which N-terminal residues distal to the phosphotyrosine directly contact residues of the four-helix bundle of the TKB domain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737992     DOI: 10.1074/jbc.M414157200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

Authors:  Hao Dou; Lori Buetow; Andreas Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

2.  Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.

Authors:  Minghua Li; Zhiqin Li; David L Morris; Liangyou Rui
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

Review 3.  Ligand discovery and virtual screening using the program LIDAEUS.

Authors:  P Taylor; E Blackburn; Y G Sheng; S Harding; K-Y Hsin; D Kan; S Shave; M D Walkinshaw
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

4.  Development of SH2 probes and pull-down assays to detect pathogen-induced, site-specific tyrosine phosphorylation of the TLR adaptor SCIMP.

Authors:  Lin Luo; Samuel J Tong; Adam A Wall; Tatiana Khromykh; Matthew J Sweet; Jennifer L Stow
Journal:  Immunol Cell Biol       Date:  2017-03-14       Impact factor: 5.126

5.  Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.

Authors:  Sigal Gery; Qi Cao; Saskia Gueller; Hongtao Xing; Ayalew Tefferi; H Phillip Koeffler
Journal:  J Leukoc Biol       Date:  2009-03-17       Impact factor: 4.962

6.  Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.

Authors:  Qingxiang Sun; Rebecca A Jackson; Cherlyn Ng; Graeme R Guy; J Sivaraman
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

Review 7.  Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.

Authors:  Melany J Wagner; Melissa M Stacey; Bernard A Liu; Tony Pawson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

8.  c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.

Authors:  Jae J Song; Miroslaw Jerzy Szczepanski; So Young Kim; Joo-Hang Kim; Jee Young An; Yong Tae Kwon; Marco A Alcala; David L Bartlett; Yong J Lee
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

9.  The Drosophila SH2B family adaptor Lnk acts in parallel to chico in the insulin signaling pathway.

Authors:  Christian Werz; Katja Köhler; Ernst Hafen; Hugo Stocker
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

Review 10.  SH2 domains: modulators of nonreceptor tyrosine kinase activity.

Authors:  Panagis Filippakopoulos; Susanne Müller; Stefan Knapp
Journal:  Curr Opin Struct Biol       Date:  2009-11-18       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.